Findings indicated that when added to standard care, semaglutide decreased the occurrence of a composite of cardiovascular-related deaths, non-fatal heart attacks, or non-fatal strokes over an average follow-up period of 39.8 9.4 months in this group compared to the placebo group
L-carnitine should not be treated as a single raw-material option in commercial formulation
Patients on a calorie-restricted plan experiencing fatigue
Pilozzi A, Carro C, Huang X (2021) Roles of -endorphin in stress, behavior, neuroinflammation, and brain energy metabolism
Bremelanotide may interact with other medications, so researchers must consult healthcare providers and assess potential interactions to ensure participant safety and study integrity